National Tuberculosis, Leprosy and Lung Disease Program

What National Tuberculosis, Leprosy and Lung Disease Program does

The National Tuberculosis, Leprosy and Lung Disease Program (NTLD-P) is a government division within Kenya's Ministry of Health, operating under the Department of National Strategic Public Health Programs. Founded in 1980 and headquartered in Nairobi, the program coordinates the national response to tuberculosis, leprosy, and lung diseases across all 47 Kenyan counties. It delivers free diagnosis, treatment, and care services through a public health facility network spanning national reference laboratories to sub-county health facilities, supplemented by community health workers, county coordinators, and a Public-Private Mix (PPM) approach engaging private clinics and corporate health services. The program serves the general Kenyan population, with particular focus on high-burden groups including men aged 20-44 (66% of TB burden), children and adolescents, people living with HIV, refugees in Dadaab and Kakuma camps, and vulnerable communities in congregate settings.

NTLD-P operates an integrated digital health stack comprising the TIBU patient management system for case tracking and treatment monitoring, TIBU-LIMS for laboratory information management, the TB Allocation system for medicine and commodity logistics, and the NLTP Dashboard for real-time national surveillance. Diagnostic capabilities include AI-driven computer-aided detection (DeepTek's Genki software) on portable digital chest X-ray machines, the TrueNat chip-based molecular platform deployed across 38 peripheral laboratories, and conventional laboratory networks. The program operates under successive National Strategic Plans (currently 2023/24-2027/28) aligned with WHO's End TB Strategy, and is funded through Kenya Ministry of Health budget allocations and grants from The Global Fund, USAID, WHO, CDC, PEPFAR, and the Bill and Melinda Gates Foundation. Key implementing partners include Amref Health Africa, Kenya Red Cross, ICF International, Stop TB Partnership, and the 47 county governments.

Name

National Tuberculosis, Leprosy and Lung Disease Program

Legal name

National Tuberculosis, Leprosy and Lung Disease Program

Website

https://nltp.co.ke

Company type

Private

Founded year

1980

Operating status

Operating

Short description

Government health program under Kenya's Ministry of Health managing tuberculosis, leprosy, and lung disease services across all 47 counties, delivering free diagnosis and treatment through public facilities, digital health systems, and community health worker networks.

Ownership category

akta.pro rank

Product category

Public Health Tuberculosis and Lung Disease Control

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Health Care and Social Assistance (62)

SIC

Services-Health Services (8000), Services-Medical Laboratories (8071)

akta.pro primary industry

Tuberculosis & Mycobacterial Diseases (HLAKAGAH)

akta.pro secondary industries

Disease-Specific Global Programs (HIV/TB/Malaria/NTDs) (HLAJAKAF), Communicable Disease Prevention & Control (HIV/AIDS, TB, Malaria, NTDs) (BPADAIAA), National Public Health Reference Laboratories (HLAJAIAA)

Keywords

• Tuberculosis control
• Leprosy treatment
• Lung disease care
• Public health program
• Digital disease surveillance

Headquarters

HQ city

Nairobi

HQ country

Kenya

HQ region

Africa

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Distribution channels5 records

Marketing channels5 records

Core offering

NTLD-P is Kenya's national government program that provides free tuberculosis, leprosy and lung disease prevention, diagnosis, treatment and care services across all 47 counties. Its core activities include TB case finding, laboratory diagnostics (including TrueNat molecular testing and AI-driven chest X-ray screening), directly observed therapy, contact tracing, TB/HIV co-infection management, and community engagement, supported by an integrated digital health stack (NLTP Dashboard, TIBU, TIBU-LIMS, TB Allocation System).

Product overview

NTLD-P operates a unified digital health ecosystem comprising the NLTP Dashboard for national surveillance and data visualization, the TIBU Patient Management System for case tracking and treatment monitoring, TIBU-LIMS for laboratory operations and specimen management, and the TB Allocation System for medicine logistics. These interconnected systems support Kenya's TB, leprosy, and lung disease program by providing end-to-end digital coverage from diagnosis through treatment completion.

Differentiator

Problem solved

Functional benefit

Brands

• TIBU: Patient management system for TB case tracking and treatment monitoring
• TIBU LIMS
• TB Allocation System

Products and services

• NLTP Dashboard Web-based data dashboard providing accurate, easy-to-access and timely TB and Leprosy surveillance statistics, treatment outcomes, and program performance metrics for program managers, county coordinators, and stakeholders.
• TIBU Patient Management System Web-based patient management system for tracking TB patients through diagnosis, treatment, and outcomes, supporting programmatic TB case management across health facilities in Kenya.
• TIBU-LIMS Laboratory Information Management System Laboratory information management system for TB diagnostics that connects specimen tracking with test results from facilities across Kenya and dispatches results in real time via SMS and email.
• TB Allocation System Medicine and commodity allocation system for managing TB drug distribution and inventory across health facilities in Kenya.

Quantifiable outcome

• 86-90% treatment completion rate with DOT vs 61% for self-administered therapy
• +2 more outcomes

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Partnerships

Twelve partnerships are on record, tiered core, major and minor.

• World Health Organization (WHO)coreStrategic or Co-development PartnerWHO provides global technical guidance, policy support, and strategic direction for TB control. Kenya aligns its National Strategic Plan with WHO's End TB Strategy and global guidance.
• Centers for Disease Control and Prevention (CDC)majorStrategic or Co-development PartnerCDC provides technical assistance and support for TB surveillance, laboratory strengthening, and program implementation.
• Amref Health AfricamajorImplementation/ SI/ Consulting PartnerAmref Health Africa supports program implementation, community engagement, capacity building, and PPM coordination.
• Kenya Red Cross SocietymajorImplementation/ SI/ Consulting PartnerKenya Red Cross implements TB programs in refugee camps (Dadaab and Kakuma) through IGAD TB grant, providing diagnosis and treatment support.
• Catholic Medical Mission Board (CMMB)minorImplementation/ SI/ Consulting PartnerCMMB supports TB workplace policy and stigma reduction programs through Red Cross/Global Fund Grant in Migori County.
• Stop TB Partnership-KenyamajorStrategic or Co-development PartnerStop TB Partnership-Kenya collaborates on advocacy, awareness campaigns like JUST-MEN forum, and coordination of TB elimination efforts.
• WACI HealthminorGTM or Marketing PartnerWACI Health co-organizes TB advocacy forums and campaigns targeting men and affected communities.
• Mombasa Cement ClinicminorChannel Partner/ Reseller/ DistributorPrivate corporate clinic engaged in active TB case finding among employees, demonstrating PPM approach effectiveness.
• Stop TB Partnership (Global)coreStrategic or Co-development PartnerGlobal partnership collaborating on introducing New Tools Project (iNTP) for rolling out innovations in diagnostics, treatments, and digital health technologies.
• ICF InternationalmajorImplementation/ SI/ Consulting PartnerICF implements IDDS project (Infectious Diseases Detection and Surveillance) under USAID Global Health Security Agenda for TB diagnostic network strengthening.
• Vital StrategiesminorStrategic or Co-development PartnerProvides technical support for tobacco control integration with TB programs at divisional level workshops.
• County GovernmentscoreStrategic or Co-development PartnerAll 47 county governments collaborate on program implementation, resource allocation, and health service delivery through county health departments.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Uganda National TB and Leprosy Programme (NTLP): Uganda's NTLP is a sibling national TB/leprosy program operating under a ministry-of-health division model, with comparable multi-donor financing (Global Fund, USAID), diagnostic-platform rollouts (TrueNat/ GeneXpert), and community health worker case-finding models similar to NTLD-P.[end of turn]"}
• South Africa National TB Programme: South Africa's national TB programme under the Department of Health is a high-burden peer with comparable CAD/AI screening pilots, drug-resistant TB scale, and digital surveillance platforms analogous to NLTP Dashboard.[end of turn]"}
• Nigeria National TB, Buruli Ulcer and Leprosy Control Programme (NTBLCP): Nigeria's NTBLCP runs the largest African national TB/leprosy program with similar Global Fund grant sizing, PPM expansion, and pediatric TB case-finding challenges relevant to NTLD-P's gaps in childhood TB notifications.[end of turn]"}
• Tanzania National TB and Leprosy Programme (NTLP): Tanzania's NTLP is a regional peer national TB and leprosy program operating under Tanzania's Ministry of Health with parallel donor mix, sub-national coordinator network, and TB surveillance digital systems analogous to TIBU and TIBU-LIMS.[end of turn]"}
• India National Tuberculosis Elimination Programme (NTEP): India's central TB elimination program is the most directly comparable national TB program; NTLD-P explicitly deployed DeepTek Genki mobile diagnostic units and ultra-portable CXR CAD across Tamil Nadu (an NTEP state), evidencing operational and platform alignment with NTEP workflows, genomics, and patient management systems. [end of turn]"}

Emerging players

• FIND (Foundation for Innovative New Diagnostics): FIND accelerates diagnostic access for poverty-related diseases and is a peer in the TB diagnostic ecosystem that NTLD-P draws on for validation, instrument rollouts (TrueNat, CAD AI), and surveillance dashboards funded by Gates Foundation partners.[end of turn]"}
• TB Alliance: TB Alliance is a product-development partnership advancing new TB drug regimens (BPaL/BPaLM) that NTLD-P would adopt into its treatment protocols; it is an emerging player shaping NTLD-P's drug-resistant TB treatment pipeline and procurement choices.[end of turn]"}

Others

• The Global Fund to Fight AIDS, Tuberculosis and Malaria: The Global Fund is NTLD-P's principal pooled financing counterparty, providing commodity procurement, health systems strengthening grants, and refugee camp support (IGAD TB grant via Kenya Red Cross); as a counterparty/financier it is a structural peer in program economics rather than a direct competitor.[end of turn]"}

Broad incumbents

• WHO Global TB Programme: WHO's Global TB Programme shapes the End TB Strategy, normative guidance, and mid-term review milestones that NTLD-P aligns its National Strategic Plans to; it functions as the global standard-setter peer for NTLD-P's policies, surveillance, and impact reporting.[end of turn]"}
• Stop TB Partnership: Stop TB Partnership is a core strategic ally of NTLD-P (Stop TB-Kenya for advocacy, JUST-MEN forums, iNTP introduction); it operates as a multi-stakeholder global TB coordination body that NTLD-P works within, making it the closest strategic umbrella peer for cross-country learning and funding pipelines.[end of turn]"}

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtwitter.com/NTLDKenya
• Facebookfacebook.com/ntldp

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Tuberculosis, Leprosy and Lung Disease Program